Sarda Proteins
Ticker >

Sarda Proteins share price

Sarda Proteins Ltd.

BSE: 519242 SECTOR: Edible Oil  4500   2   0

46.50
0 0
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 46.58

Today's Low

₹ 46.5

52 Week High

₹ 78.51

52 Week Low

₹ 37.7

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 8.03 Cr.

Enterprise Value

₹ 7.84 Cr.

No. of Shares

0.17 Cr.

P/E

0

P/B

5.1

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  9.13

CASH

₹ 0.18 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

28.41 %

EPS (TTM)

₹  -0.24

Sales Growth

-46.14%

ROE

-2.08 %

ROCE

0.55%

Profit Growth

-110.74 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-46.14%
3 Year2.38%
5 Year0.5%

Profit Growth

1 Year-110.74%
3 Year-200.11%
5 Year13.7%

ROE%

1 Year-2.08%
3 Year5.84%
5 Year2.18%

ROCE %

1 Year0.55%
3 Year6.45%
5 Year4.77%

Debt/Equity

0

Price to Cash Flow

-26.64

Interest Cover Ratio

498.346153846154

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 28.41 0
Dec 2023 28.41 0
Sep 2023 28.41 0
Jun 2023 28.41 0
Mar 2023 28.41 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 98.0703908682117.

 Limitations

  • The company has shown a poor profit growth of -200.112578535841% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.37949366593677% for the Past 3 years.
  • Company has a poor ROE of 5.84102270997095% over the past 3 years.
  • Company has negative cash flow from operations of -0.301244.
  • The company has a low EBITDA margin of 0.0346771535554258% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 1592.487.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 2.27 0.74 0.24 0 1
Total Expenditure 2.31 0.77 0.28 0.05 1.04
Operating Profit -0.04 -0.04 -0.04 -0.05 -0.04
Other Income 0.04 0.04 0.04 0.04 0.04
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 0.01 0 -0.01 0.01
Tax 0 0.05 0 0 0
Profit After Tax 0 -0.04 0 -0.01 0.01
Adjusted EPS (Rs) 0.01 -0.24 -0.01 -0.03 0.04

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 7.22 5.4 11.36 10.76 5.8
Total Expenditure 7.32 5.3 11.38 10.49 5.94
Operating Profit -0.1 0.1 -0.02 0.27 -0.15
Other Income 0.03 0.08 0.08 0.09 0.16
Interest 0 0 0 0 0
Depreciation 0.01 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.09 0.17 0.06 0.35 0.01
Tax 0.04 0.14 0.08 0.05 0.05
Net Profit -0.12 0.03 -0.02 0.31 -0.03
Adjusted EPS (Rs.) -0.72 0.19 -0.12 1.78 -0.19

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 2.5 2.5 2.5 2.5 2.5
Total Reserves -0.44 -0.41 -0.43 -0.12 -0.15
Borrowings 0 0 0 0 0
Other N/C liabilities -0.31 -0.29 -0.21 -0.15 -0.11
Current liabilities 0.03 0.04 0.03 0.04 0.02
Total Liabilities 1.79 1.85 1.91 2.27 2.27
Assets
Net Block 0.02 0.01 0.01 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 1.76 1.84 1.9 2.27 2.27
Total Assets 1.79 1.85 1.91 2.27 2.27
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -0.09 0.17 0.06 0.35 0.01
Adjustment -0.09 -0.07 -0.08 -0.08 -0.16
Changes in Assets & Liabilities -0.41 -0.12 -0.02 -0.17 -0.15
Tax Paid 0 -0.03 -0.01 0 0
Operating Cash Flow -0.59 -0.05 -0.05 0.1 -0.3
Investing Cash Flow 0.11 0.09 0.08 0.09 0.16
Financing Cash Flow 0.01 -0.01 0 0 0
Net Cash Flow -0.47 0.03 0.03 0.19 -0.14

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 28.41 28.41 28.41 28.41 28.41
ajay data 2.03 2.03 2.03 2.03 2.03
babu lal data 3.67 3.67 3.67 3.67 3.67
deepak data 2.03 2.03 2.03 2.03 2.03
mohini devi 0.87 0.87 0.87 0.87 0.87
nidhie a data - 0.87 0.87 0.87 0.87
ritika data 0.87 0.87 0.87 0.87 0.87
ritika vegetable oil priv... 18.08 18.08 18.08 18.08 18.08
nidhi data 0.87 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 71.59 71.59 71.59 71.59 71.59
atul pratap shah 1.76 1.76 1.76 1.76 1.76
guttikonda rajasekhar 1.86 1.86 1.86 1.86 1.86
guttikonda vara lakshmi 3.57 3.57 3.57 3.57 3.57
llp - 0.01 0.01 0.01 0.01
neelima karlapudi 2.63 2.63 2.63 2.63 2.63
meena rajani parekh - 1.19 1.19 1.19 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Sarda Proteins informs about disclosure 3 Apr 2024, 5:20PM Sarda Proteins - Quaterly Results13 Feb 2024, 5:32PM Sarda Proteins - Quaterly Results13 Feb 2024, 5:32PM Sarda Proteins informs about appointment of CFO1 Dec 2023, 2:09PM Sarda Proteins - Quaterly Results7 Nov 2023, 5:19PM Sarda Proteins informs about scrutinizer’s report30 Sep 2023, 3:14PM Sarda Proteins informs about non-applicability of large corporate entity4 Apr 2023, 2:13PM Sarda Proteins informs about closure of trading window30 Mar 2023, 2:05PM Sarda Proteins informs about loss of share certificate23 Feb 2023, 2:18PM Sarda Proteins informs about appointment of CFO 30 Jan 2023, 4:34PM Sarda Proteins - Quaterly Results30 Jan 2023, 2:11PM Sarda Proteins - Quaterly Results30 Jan 2023, 2:11PM Sarda Proteins - Quaterly Results30 Jan 2023, 2:11PM Sarda Proteins - Quaterly Results19 Oct 2022, 1:56PM Sarda Proteins - Quaterly Results19 Oct 2022, 1:56PM Sarda Proteins - Quaterly Results19 Oct 2022, 1:56PM Sarda Proteins informs about annual report 25 Aug 2022, 4:52PM Sarda Proteins - Quaterly Results5 Aug 2022, 2:06PM Sarda Proteins - Quaterly Results5 Aug 2022, 2:06PM Sarda Proteins - Quaterly Results5 Aug 2022, 2:06PM Sarda Proteins informs about closure of trading window31 Mar 2022, 2:59PM Sarda Proteins informs about press release11 Feb 2022, 12:08PM Sarda Proteins - Quaterly Results10 Feb 2022, 2:07PM Sarda Proteins - Quaterly Results10 Feb 2022, 2:07PM Sarda Proteins - Quaterly Results10 Feb 2022, 2:07PM Sarda Proteins informs about closure of trading window31 Dec 2021, 2:11PM Sarda Proteins informs about voting results18 Sep 2021, 5:07PM Sarda Proteins informs about board meeting3 Aug 2021, 5:00PM Sarda Proteins informs about newspaper advertisement26 Aug 2020, 12:38PM
Last Updated on:
Brief about Sarda Proteins
X